• Mutation; HGNC; HGNC:9177; POLE; Simple; p.His67Asn (c.199C>A); ClinVar=VCV000473501; Zygosity=Unspecified (PubMed=27894751; Direct_author_submission).
  
• Mutation; HGNC; HGNC:9177; POLE; Simple; p.Ala1967Val (c.5900C>T); ClinVar=VCV000246263; Zygosity=Unspecified (PubMed=27894751; Direct_author_submission).
  
• Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asp368Tyr; Zygosity=Unspecified (PubMed=27894751; Direct_author_submission).
  
• Mutation; HGNC; HGNC:9177; POLE; Simple; p.Ala832Thr; Zygosity=Unspecified (PubMed=27894751; Direct_author_submission).
  
• Mutation; HGNC; HGNC:9177; POLE; Simple; p.Cys1642Tyr; Zygosity=Unspecified (PubMed=27894751; Direct_author_submission).
  
• Mutation; HGNC; HGNC:9177; POLE; Simple; p.Gly2076Val; Zygosity=Unspecified (PubMed=27894751; Direct_author_submission).
  
• Mutation; HGNC; HGNC:9177; POLE; Simple; p.Leu2207Ile; Zygosity=Unspecified (PubMed=27894751; Direct_author_submission).
  

PubMed=19920829; DOI=10.1038/sj.bjc.6605448; PMCID=PMC2813756
Karim S. El-Sahwi, Stefania Bellone, Emiliano Cocco, Marilisa Cargnelutti, Francesca Casagrande, Marta Bellone, Maysa Abu-Khalaf, Natalia Buza, Fattaneh A. Tavassoli, Pei Hui, Dan-Arin Silasi ...Show all 16 authors... , Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, Alessandro D. Santin; Show fewer authors
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma.
Br. J. Cancer 102:134-143(2010)

PubMed=21246534; DOI=10.1002/cncr.25891; PMCID=PMC3128671
Joyce Varughese, Emiliano Cocco, Stefania Bellone, Maria de Leon, Marta Bellone, Paola Todeschini, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, Alessandro D. Santin;
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody.
Cancer 117:3163-3172(2011)

PubMed=23891627; DOI=10.1016/j.ajog.2013.07.020
Diana P. English, Stefania Bellone, Emiliano Cocco, Ileana Bortolomai, Sergio Pecorelli, Salvatore Lopez, Dan-Arin Silasi, Peter E. Schwartz, Thomas J. Rutherford, Alessandro D. Santin;
Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2).
Am. J. Obstet. Gynecol. 209:465.e1-465.e9(2013)

PubMed=27894751; DOI=10.1016/j.ygyno.2016.11.023; PMCID=PMC5183545
Stefania Bellone, Eliana Bignotti, Silvia Lonardi, Francesca Ferrari, Floriana Centritto, Alice Masserdotti, Francesca Pettinella, Jonathan D. Black, Gulden Menderes, Gary Altwerger, Pei Hui ...Show all 29 authors... , Salvatore Lopez, Christopher de Haydu, Elena Bonazzoli, Federica Predolini, Luca Zammataro, Emiliano Cocco, Federico Ferrari, Antonella Ravaggi, Chiara Romani, Fabio Facchetti, Enrico Sartori, Franco Edoardo Odicino, Dan-Arin Silasi, Babak Litkouhi, Elena Ratner, Masoud Azodi, Peter E. Schwartz, Alessandro D. Santin; Show fewer authors
Polymerase epsilon (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro.
Gynecol. Oncol. 144:146-152(2017)